Skip to navigation | Skip to main content | Skip to footer

Professor Clifford Garratt (MA MBBS DM FRCP FESC) - publications

List of publications

2013

  • Zaki A, Zaidi A, Newman WG, Garratt CJ. (2013). Advantages of a subcutaneous implantable cardioverter-defibrillator in LAMP2 hypertrophic cardiomyopathy. Journal of Cardiovascular Electrophysiology, eScholarID:198227
  • Colman MA, Aslanidi OV, Kharche S, Boyett MR, Garratt CJ, Hancox JC, Zhang H. (2013). Pro-arrhythmic effects of atrial fibrillation-induced electrical remodelling- insights from 3D virtual human atria. Journal of Physiology, eScholarID:198224
  • Garratt CJ, Saeed Y. (2013). The Year in Cardiology 2012; arrhythmia and pacing. European Heart Journal, 34(5), 333-337. eScholarID:198203

2012

  • Stott DJ, Dewar RI, Garratt CJ, Griffith KE, Harding NJ, James MA, Lane DA, Petty DR, Smith PA, Somerville MH, Trueland J. (2012). RCPE UK Consensus Conference on approaching the comprehensive management of atrial fibrillation; evolution or revolution? J R Coll Physicians Edinb, 42(18), 3-4. eScholarID:173247
  • Caldwell J, Moreton N, Khan N, Kerzin-Storrar L, Metcalfe K, Newman W, Garratt CJ. (2012). The clinical management of relatives of young sudden unexplained death victims; implantable defibrillators are rarely indicated. Heart, 98(8), 631-636. eScholarID:173246 | DOI:10.1136/heartjnl-2011-300924
  • Caldwell JC, Woolfson P, Clarke B, Garratt CJ. (2012). Ventricular fibrillation following successful DC cardioversion for atrial fibrillation. Pacing Clin Electrophysiol, 35, e361-e364. eScholarID:198399
  • Aslanidi OV, Al-Owais M, Benson AP, Coleman M, Garratt CJ, Gilbert SH, Greenwood JP, Holden AV, Kharche S, Kinnell E, Pervolaraki E, Plein S, Stott J, Zhang H. (2012). Virtual tissue engineering of the human atrium: modelling pharmacological actions on atrial arrhythmogenesis. Eur J Pharm Sci, 46(4), 209-221. eScholarID:198205

2011

  • Aslanidi, OV; Al-Owais, M; Benson, AP; Colman, M; Garratt, CJ; Gilbert, SH; Greenwood, JP; Holden, AV; Kharche, S; Kinnell, E; Pervolaraki, E; Plein, S; Stott, J; Zhang, H. (2011). Virtual tissue engineering of the human atrium: modelling pharmacological actions on atrial arrhythmogenesis. Eur J Pharm Sci -, 2011 DOI:10.1016/j.ejps.2011.08.014, eScholarID:153418 | DOI:10.1016/j.ejps.2011.08.014

2010

  • Eisenberger M, Davidson NC, Todd DM, Garratt CJ, Fitzpatrick AP. (2010). A new approach to confirming or excluding ventricular pre-excitation on a 12-lead ECG. Europace, 12, 119-123. eScholarID:198405
  • Hall MC, Kirubakaran S, Choudhury R, Abidin N, Peters NS, Garratt CJ. (2010). Effects of angiotensin receptor blockade on atrial electrical remodelling and the "second factor" in a goat burst paced model of atrial fibrillation. J Renin Angiotensin Aldosterone Syst, 11(4), 222-233. eScholarID:198221
  • Garratt CJ, Elliott P, Behr E, Camm AJ, Cowan C, Cruikshank S, Grace A, Griffith MJ, Jolly A, Lambiase P, McKeown P, O'Callagan P, Stuart G, Watkins H. (2010). Heart Rhythm UK position statement on clinical indications for implantable cardioverter defibrillators in adult patients with familial sudden cardiac death syndromes. Europace, 12(8), 1156-1175. eScholarID:198213
  • Caldwell JC, Fath-Ordoubadi F, Garratt CJ. (2010). Right coronary artery damage during cavotricuspid isthmus ablation. Pacing Clin Electrophysiol, 33, e110-e113. eScholarID:198404
  • Caldwell JC, Mamas MA, Neyses L, Garratt CJ. (2010). What are the thromboembolic risks of heart failure combined with chronic or paroxysmal AF? J Card Fail, 16, 340-347. eScholarID:198403

2009

  • Mamas MM, Caldwell JC, Chacko SSM, Garratt CJ, Fath-Ordoubadi F, Neyses L. (2009). A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure. European Journal of Heart Failure, 11(7), 676. eScholarID:1d20113 | DOI:10.1093/eurjhf/hfp085
  • Caldwell JC, Contractor H, Petkar S, Ali R, Clarke B, Garratt CJ, Neyses L, Mamas MA. (2009). Atrial fibrillation is underrecognised in chronic heart failure: insights from a heart failure cohort treated with cardiac resynchronisation therapy. Europace, 11, 1295-1300. eScholarID:198406

2005

  • Zhang H, Garratt CJ, Zhu J, Holden AV. (2005). Role of up-regulation of IK1 in action potential shortening associated with atrial fibrillation in humans. Cardiovascular Research, 66(3), 493-502. eScholarID:1d26234 | DOI:10.1016/j.cardiores.2005.01.020

2004

  • Todd DM, Fynn SP, Walden AP, Hobbs WJ, Arya S, Garratt CJ. (2004). Repetitive four-week periods of atrial electrical remodelling promote stability of atrial fibrillation. Circulation, 109, 1434-9. eScholarID:1d26233 | DOI:10.1161/01.CIR.0000124006.84596.D9

2003

  • Fynn S, D Todd, WJC Hobbs, KL Armstrong, Fitzpatrick AP, Garratt CJ. (2003). The effect of amiodarone on dispersion of atrial refractoriness and cycle length in patients with atrial fibrillation. Journal of Cardiovascular Electrophysiology, 14, 485-491. eScholarID:1d25611 | DOI:10.1046/j.1540-8167.2003.02388.x

2002

  • S P Fynn, D M Todd, W J Hobbs, L J Armstrong, Fitzpatrick AP, Garratt CJ. (2002). Clinical evaluation of a policy of early repeated internal cardioversion for recurrence of atrial fibrillation. Journal of Cardiovascular Electrophysiology, 13, 135-141. eScholarID:1d24080 | DOI:10.1046/j.1540-8167.2002.00135.x